Squarepoint
ZURA icon

Squarepoint’s Zura Bio ZURA Stock Holding History

Squarepoint’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
27,164
-17,775
-40% -$84.7K ﹤0.01% 4113
2026
Q1 		$267K Buy
44,939
+11,138
+33% +$67.3K ﹤0.01% 3794
2025
Q4 		$177K Buy
33,801
+8,680
+35% +$34.3K ﹤0.01% 3906
2025
Q3 		$109K Buy
+25,121
New +$45.2K ﹤0.01% 4096
2025
Q2 		– Sell
-15,238
Closed -$19.7K – 5165
2025
Q1 		$19.7K Sell
15,238
-8,134
-35% -$12.8K ﹤0.01% 4440
2024
Q4 		$58.4K Sell
23,372
-22,083
-49% -$78.7K ﹤0.01% 4815
2024
Q3 		$185K Buy
+45,455
New +$170K ﹤0.01% 3715

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Squarepoint's ZURA Position: Q2 2026 in Review

Squarepoint reduced its Zura Bio (ZURA) stake by 40% in Q2 2026, selling an estimated $84.7K and leaving 27,164 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #4113.

Squarepoint first reported a position in ZURA in Q3 2024 and has held it in 7 quarters since. The position peaked at $267K in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Squarepoint held 27,164 shares of Zura Bio worth $160K as of Q2 2026.
  • Squarepoint sold 17,775 Zura Bio shares in Q2 2026, an estimated $84.7K.
  • Zura Bio made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4113 holding.
  • Squarepoint first reported a position in Zura Bio in Q3 2024 and has held it in 7 quarters since.
  • Squarepoint's Zura Bio position peaked at $267K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.